In this issue
If a Chinese medical research institute applies for the patent of a US brand-name drug that might cure COVID-19, as a ‘secondary use’ invention does it constitute squatting?
With the deadly COVID-19 virus forcing businesses into shutdown mode, PRC labour laws are scrambling to regulate a new norm for work conditions and payment standards.
In a new era, High net worth individuals and China’s 'mass affluent' can now manage legal risks with once exclusive products and wealth strategies
India has growing internet penetration and a large unbanked population, but Chinese investors need to be wary of much tighter regulations when entering this market